Article Cited by others


Bedaquiline: A novel drug to combat multiple drug-resistant tuberculosis

Goel Divya

Year : 2014| Volume: 5| Issue : 1 | Page no: 76-78

   This article has been cited by
1 Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis
W. David Hong,Peter D. Gibbons,Suet C. Leung,Richard Amewu,Paul A. Stocks,Andrew Stachulski,Pedro Horta,Maria L. S. Cristiano,Alison E. Shone,Darren Moss,Alison Ardrey,Raman Sharma,Ashley J. Warman,Paul T. P. Bedingfield,Nicholas E. Fisher,Ghaith Aljayyoussi,Sally Mead,Maxine Caws,Neil G. Berry,Stephen A. Ward,Giancarlo A. Biagini,Paul M. O’Neill,Gemma L. Nixon
Journal of Medicinal Chemistry. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Novel and revisited approaches in antituberculosis drug discovery
Jennifer Herrmann,Jan Rybniker,Rolf Müller
Current Opinion in Biotechnology. 2017; 48: 94
[Pubmed]  [Google Scholar] [DOI]
3 Cost-Effectiveness of Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis in the Republic of Korea
Hae-Young Park,Hye-min Ku,Hyun-Soon Sohn,Hae-Sook Seo,Hyun Yung Lee,Kyung Hwa Lim,Jin-Won Kwon
Clinical Therapeutics. 2016;
[Pubmed]  [Google Scholar] [DOI]


Read this article